Xinyu Li (X Li)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Decision Making

Cardiovascular Disease

Top Venues

PharmacoEconomics

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Aniek de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten J Postma, Peter Ruben van Dijk, Talitha L Feenstra
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data. PharmacoEconomics 42 (9) (2024)
Lisa Aniek de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten J Postma, Peter Ruben van Dijk, Talitha L Feenstra
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data. PharmacoEconomics (2024)
Xinyu Li, Louise A Donnelly, Roderick C Slieker, Joline Wilhelma Johanna Beulens, Leendert M 't Hart, Petra J M Elders, Ewan R Pearson, Anoukh van Giessen, Shelby D Reed, Talitha L Feenstra
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia 67 (7) (2024)
Lisa Aniek de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten J Postma, Peter Ruben van Dijk, Talitha L Feenstra
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data. PharmacoEconomics 42 (9) (2024)
Lisa Aniek de Jong, Xinyu Li, Sajad Emamipour, Sjoukje van der Werf, Maarten J Postma, Peter Ruben van Dijk, Talitha L Feenstra
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data. PharmacoEconomics 42 (9) (2024)
Xinyu Li, Louise A Donnelly, Roderick C Slieker, Joline Wilhelma Johanna Beulens, Leendert M 't Hart, Petra J M Elders, Ewan R Pearson, Anoukh van Giessen, Shelby D Reed, Talitha L Feenstra
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia 67 (7) (2024)
Xinyu Li, Louise A Donnelly, Roderick C Slieker, Joline Wilhelma Johanna Beulens, Leendert M 't Hart, Petra J M Elders, Ewan R Pearson, Anoukh van Giessen, Shelby D Reed, Talitha L Feenstra
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia (2024)
Xinyu Li, Louise A Donnelly, Roderick C Slieker, Joline Wilhelma Johanna Beulens, Leendert M 't Hart, Petra J M Elders, Ewan R Pearson, Anoukh van Giessen, Shelby D Reed, Talitha L Feenstra
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes. Diabetologia 67 (7) (2024)
Xinyu Li, Anoukh van Giessen, James Altunkaya, Roderick C Slieker, Joline Wilhelma Johanna Beulens, Leendert M 't Hart, Ewan R Pearson, Petra J M Elders, Talitha L Feenstra, Shelby D Reed
Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups. Diabetes care (2023)
Lisa Aniek de Jong, Xinyu Li, S Emamipour, Sjoukje van der Werf, M J Postma, Peter Ruben van Dijk, Talitha L Feenstra
Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality. PharmacoEconomics - open (2023)
Xinyu Li, Rudolf Hoogenveen, Mohamed El Alili, Saskia Knies, Junfeng Wang, Joline Wilhelma Johanna Beulens, Petra J M Elders, Giel Nijpels, Anoukh van Giessen, Talitha L Feenstra
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry. PharmacoEconomics (2023)
Xinyu Li, Fang Li, Junfeng Wang, Anoukh van Giessen, Talitha L Feenstra
Prediction of complications in health economic models of type 2 diabetes: a review of methods used. Acta diabetologica (2023)